Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

DNA Script successfully synthesizes world's first 150-nucleotide strand of DNA

DNA Script, the global leader in the development of enzymatic DNA synthesis, today announced that it has successfully synthesized the world's first 150-nucleotide strand of DNA by de novo enzymatic synthesis.

3 Oct 2018

Natural nanoscopic particles identified as possible diagnostic tool for Alzheimer's

Exosomes are natural nanoscopic particles released by most cell types, and are currently the focus of research because they represent a possible tool for the diagnosis of Alzheimer's. These particles are not so easy to isolate, and nanotechnology may help in this process.

3 Oct 2018

Why patients with ALL relapse after CAR-T cell therapy

Researchers have made a new discovery about a rare mechanism that triggers the relapse of acute lymphoblastic leukemia (ALL) after CAR T cell therapy.

1 Oct 2018

Why patients with ALL relapse after CAR-T cell therapy

Researchers have made a new discovery about a rare mechanism that triggers the relapse of acute lymphoblastic leukemia (ALL) after CAR T cell therapy.

1 Oct 2018

Eisai's antiepileptic drug receives FDA approval to treat partial-onset seizures in pediatric patients

Eisai Co., Ltd. announced today that its U.S. subsidiary Eisai Inc. received approval from the U.S. Food and Drug Administration for an indication expansion for Eisai's antiepileptic drug Fycompa (perampanel) to cover partial-onset seizures in pediatric patients with epilepsy 4 years of age and older.

1 Oct 2018

CNL, TRIUMF team up to enable revolutionary cancer treatment

TRIUMF, Canada's particle accelerator center, and Canadian Nuclear Laboratories, Canada's premier nuclear science and technology organization, are pleased to announce that they have agreed to pursue a strategic partnership around the commercial production of Actinium-225, a rare medical isotope that has the potential to serve as the basis of new ground-breaking cancer treatments.

28 Sep 2018

New Prosperity Partnerships projects that link research with industry unveiled

Seven new Prosperity Partnerships projects that will build links between the UK's research base and leading industry partners such as AkzoNobel , AstraZeneca, Google, Rolls-Royce, Tata Steel, and Weir Group, plus small-to-medium enterprise, Oxford PV will be unveiled today by the Engineering and Physical Sciences Research Council (EPSRC) at Prince Philip House, Carlton Terrace, London.

27 Sep 2018

CytoSen receives favorable response from FDA to its pre-IND meeting package for CSTD002-NK

CytoSen Therapeutics, a private biopharmaceutical company accelerating innovation in Natural Killer cell therapy, today announced it has received a favorable response from the U.S. Food and Drug Administration to its pre-Investigational New Drug meeting package for the proposed Phase 2 trial of CytoSen's adoptive NK cell therapy, CSTD002-NK, for the reduction of relapse in high risk acute myeloid leukemia or myelodysplastic syndrome in patients undergoing haploidentical hematopoietic stem cell transplantation.

27 Sep 2018

Fina Biosolutions receives patent for expression and purification of the conjugate vaccine protein

Fina Biosolutions announces that the United States Patent and Trademark Office has issued a patent for expression and purification of the conjugate vaccine protein CRM197 in E. coli.

27 Sep 2018

Updated model of PAXMAN Scalp Cooling System launched

British scalp cooling expert, PAXMAN have launched the latest model of the PAXMAN Scalp Cooling System. Following successful launch in the US this updated model is being rolled out to the UK and rest of world markets.

From Paxman 27 Sep 2018

Cornwall and Chongqing Haifu partners to introduce HIFU tumor therapy system

Cornwall Medical Group enters a strategic partnership with the world's leading medical equipment and integrated solutions provider, Chongqing Haifu Medical Technology Co., Ltd., to introduce innovative high-intensity focused ultrasound tumor therapy system to Hong Kong, positioned to be the first minimally-invasive & non-invasive center in town.

27 Sep 2018

RTI Surgical showcases innovative spine portfolio at NASS 2018

RTI Surgical, Inc., a global surgical implant company, will showcase research reinforcing the strength of its spine portfolio, notably the Fortilink IBF series featuring TETRAfuse 3D Technology, at the North American Spine Society's 33rd Annual Meeting in Los Angeles, September 26-29.

26 Sep 2018

RTI's TETRAfuse 3D Technology wins 2018 Spine Technology Award

RTI Surgical, Inc., a global surgical implant company, announced its TETRAfuse 3D Technology won a 2018 Spine Technology Award from Orthopedics This Week, a widely read publication in the orthopedics industry.

25 Sep 2018

Novartis announces winners of 2018 eXcellence in Ophthalmology Vision Award

Novartis announced the winners of the 2018 eXcellence in Ophthalmology Vision Award for nonprofit eye health initiatives at EURETINA 2018.

25 Sep 2018

Alexion announces positive results from Phase 3 PREVENT study of Soliris in patients with NMOSD

Alexion Pharmaceuticals, Inc. today announced positive topline results from the Phase 3 PREVENT study of Soliris in patients with anti-aquaporin-4 auto antibody-positive neuromyelitis optica spectrum disorder.

24 Sep 2018

IME Medical Electrospinning establishes state-of-the-art manufacturing lab facilities

Medical Technology company IME Medical Electrospinning, developer, producer and scientific partner in the field of biomedical electrospinning processes and equipment, today announced that its high-end laboratory and a brand new set of cleanrooms have become operational.

24 Sep 2018

Biogen and Eisai announce results of LTE Phase 1b study of aducanumab for treating MCI

Biogen and Eisai Co., Ltd. announced results from a recent analysis of the ongoing long-term extension Phase 1b study of aducanumab, an investigational treatment for mild cognitive impairment due to Alzheimer's disease and mild AD dementia.

24 Sep 2018

CHMP recommends approval of Gilenya for treatment of multiple sclerosis in children, adolescents

Novartis today announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval of Gilenya (fingolimod) for the treatment of children and adolescents 10 to 17 years of age with relapsing remitting forms of multiple sclerosis.

24 Sep 2018

Eisai receives approval for partial label change of DC Bead device for transcatheter arterial embolization

Eisai Co., Ltd. announced that it has received approval for a partial label change for the vascular embolization device DC Bead in Japan.

24 Sep 2018

China NMPA approves LENVIMA for treatment of unresectable hepatocellular carcinoma

Eisai Co., Ltd. and Merck & Co., Inc., Kenilworth N.J., U.S.A., known as MSD outside of the United States and Canada, announced that the China National Medical Products Administration approved the kinase inhibitor LENVIMA (lenvatinib) as a single agent for the treatment of patients with unresectable hepatocellular carcinoma who have not received prior systemic therapy.

24 Sep 2018

Manufacturing News and Research

Further Reading

DNA Script successfully synthesizes world's first 150-nucleotide strand of DNA

Natural nanoscopic particles identified as possible diagnostic tool for Alzheimer's

Why patients with ALL relapse after CAR-T cell therapy

Why patients with ALL relapse after CAR-T cell therapy

Eisai's antiepileptic drug receives FDA approval to treat partial-onset seizures in pediatric patients

CNL, TRIUMF team up to enable revolutionary cancer treatment

New Prosperity Partnerships projects that link research with industry unveiled

CytoSen receives favorable response from FDA to its pre-IND meeting package for CSTD002-NK

Fina Biosolutions receives patent for expression and purification of the conjugate vaccine protein

Updated model of PAXMAN Scalp Cooling System launched

Cornwall and Chongqing Haifu partners to introduce HIFU tumor therapy system

RTI Surgical showcases innovative spine portfolio at NASS 2018

RTI's TETRAfuse 3D Technology wins 2018 Spine Technology Award

Novartis announces winners of 2018 eXcellence in Ophthalmology Vision Award

Alexion announces positive results from Phase 3 PREVENT study of Soliris in patients with NMOSD

IME Medical Electrospinning establishes state-of-the-art manufacturing lab facilities

Biogen and Eisai announce results of LTE Phase 1b study of aducanumab for treating MCI

CHMP recommends approval of Gilenya for treatment of multiple sclerosis in children, adolescents

Eisai receives approval for partial label change of DC Bead device for transcatheter arterial embolization

China NMPA approves LENVIMA for treatment of unresectable hepatocellular carcinoma

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest Life Science News